Evolution of SARS-CoV-2 Strains in Senegal: From a Wild Wuhan Strain to the Omicron Variant

Author:

Gueye KhadimORCID,Padane Abdou,Diédhiou Cyrille Kouligueul,Ndiour Samba,Diagne Ndéye Diabou,Mboup Aminata,Mbow Moustapha,Lo Cheikh IbrahimaORCID,Leye Nafissatou,Ndoye Aissatou Sow,Ndiaye Anna Julienne Selbé,Ndiaye Seyni,Lo Gora,Wade Djibril,Ahouidi Ambroise,Diaw Papa Alassane,Sarr Marièma,Beye Mamadou,Cissé Badara,Sokhna Cheikh,Camara Makhtar,Touré Kane Ndéye Coumba,Mboup Souleymane

Abstract

The coronavirus disease 2019 (COVID-19) is a contagious disease caused by a new coronavirus called SARS-CoV-2. The first case was discovered in Wuhan, China, in December 2019, raising concerns about the emergence of a new coronavirus that poses a significant public health risk. The objective of this study, based on data collected and sequenced at the Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formations (IRESSEF), is to characterize the pandemic evolution, establish a relationship between the different strains in each wave, and finally determine the phylodynamic evolution of the pandemic, utilizing microreact simulations. The study shows that SARS-CoV-2 strains have evolved over time and the variability of the virus is characterized by sequencing during each wave, as is its contagiousness (the speed at which it spreads). The pandemic has spread at a rate of 44.34 cases/week during the first wave. Twelve weeks later it has risen to 185.33 cases/week during the second wave. Twenty-three weeks into the pandemic, the numbers have reached 681.77 cases/week during the third wave. During the fourth wave, the rate of infection was found to decrease slightly at 646 cases/week between early December 2021 and mid-January 2022. Data collected during this study also provided us with a geographical distribution of COVID-19, indicating that the epidemic started in Dakar before spreading inland.

Funder

European and Developing Countries Clinical Trials Partnership

Publisher

MDPI AG

Subject

General Medicine

Reference25 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

2. WHO|Novel Coronavirus—China. WHO n.d http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/

3. WHO Director-General’s Remarks at the Media Briefing on 2019-nCoV on 11 February 2020 n.d https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020

4. Coronavirus-West-Africa—Sahel and West Africa Club Secretariat n.d https://www.oecd.org/swac/coronavirus-west-africa/

5. Senegal Reports First COVID-19 Case. WHO|Regional Office for Africa n.d https://www.afro.who.int/news/senegal-reports-first-COVID-19-case

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3